[Philadelphia Session] Lessons in Herding Cats: Business Development for Life Science Companies

Add this event to your calendar:
24/10/2017 13:00 24/10/2017 15:00 America/New_York [Philadelphia Session] Lessons in Herding Cats: Business Development for Life Science Companies Quorum at the University City Science Center , 3711 Market Street, 8th Floor , Philadelphia , PA 19104 Johnson & Johnson Innovation, JLABS false DD/MM/YYYY

[Philadelphia Session] Lessons in Herding Cats: Business Development for Life Science Companies

Quorum at the University City Science Center , 3711 Market Street, 8th Floor , Philadelphia , PA 19104

October 24, 2017 from 13:00 PM to 15:00 PM (EST)

$10 - $35

What are the ins and outs of making a partnership, from the perspective of a strategic investor?

The business development professional's purpose is to optimize optionality and long term value at each stage of a company's life. How do you determine the direction that will add the most value to your company? How do you avoid the constant pursuit of "shiny objects"? How do you know when it's the right time for a strategic partnership?

In this workshop, you'll hear from a deal making team at Johnson & Johnson Innovation and learn fundamental business development skills to help you successfully evaluate and manage strategic alliances and other potential growth opportunities.

Topics will include:

  • Strategic alliance process management
  • Concepts in valuation
  • Technical diligence
  • Communication and negotiation skills

This workshop is geared towards business development professionals and management teams of life science startups.

Event Partners:


Jill McManus | Finance Director, Johnson & Johnson Innovation read bio»
Nancy Ondovik | Sr. Director, Transactions, Johnson & Johnson read bio»
Erin Washington | Senior Manager, Transactions & Business Analytics, Johnson & Johnson Innovation read bio»

11:00 AM | Registration Opens, Networking & Lunch
11:30 AM | Presentations
12:30 PM | Q&A
1:00 PM | Program Close

$35 | General Public
$20 | Student/Academic
$45 | At the door

Quorum at the University City Science Center
3711 Market Street, 8th Floor
Philadelphia, PA 19104

Venue Info:
A credit-card only parking garage is located at 3711 Market Street, with the entrance in the rear on Filbert Street. Driving west on Market, turn right onto 36th Street and make the first left onto Filbert. The garage is about ¾ of the way up the block on the left. More information can be found here:

Speakers' Biographies:
Jill McManus | Finance Director, Johnson & Johnson Innovation
Jill has been with Johnson & Johnson for 11 years. In her current role, she is the finance director for the Boston J&J Innovation Center focusing on early stage deal structures with external partners. Prior to this role, Jill supported the DePuy Synthes organization. She started as a Senior Financial Analyst in Recon Supply Chain where she worked on the divestiture of the New Bedford instrument facility. She has held various positions including Supply Chain Finance Manager with Codman, Financial Reporting Manager in Spine, and Finance Manager, Sports Commercial. During her time in Spine, she worked on the Synthes integration, leading the Marketing and R&D organization design. While in Sports, Jill was the Financial Lead for the distributor sales force to direct transition and was part of the team for the Olive Visualization acquisition.
Prior to J&J, she worked for six years with State Street and three years prior with Teradyne.
Jill earned her BS in Accounting from Bentley College. She lives in MA with her husband and two children, Matt and Olivia.
Connect with Jill:   Connect on LinkedIn

Nancy Ondovik | Senior Director, Translactions, Johnson & Johnson
Nancy Ondovik serves as Senior Director of Business Development & Licensing at Johnson & Johnson and is responsible for the evaluation, negotiation, and execution of business development transactions in the Cardiovascular and Metabolic Disease therapeutic area. Nancy is also responsible for driving the internal deal approval process and coordinating the development of business cases which support traditional and/or creative deal structures.
Nancy has negotiated numerous important strategic collaborations and commercial arrangements in diabetes, obesity, heart failure, and thrombosis. Prior to her current position, Nancy was Director, Corporate Development and responsible for acquisition deals supporting the pharmaceutical group. During her 6 year tenure with the M&A group, Nancy worked closely with the oncology team to identify and assess multiple company acquisition opportunities and in 2009, led the team responsible for the acquisition of Cougar Biotechnology. Nancy joined the Johnson & Johnson family of companies in 1998 at Ortho Biotech, where she held positions of increasing responsibility in Market Research and New Business Development before joining the Corporate M&A group.
Nancy holds a Bachelor of Science in Pharmacy and a Doctor of Pharmacy degree, from Rutgers, The State University of New Jersey. In addition, Nancy holds a MBA, with a concentration in Finance, from Rutgers Business School.

Erin Washington | Senior Manager, Transactions & Business Analytics, Johnson & Johnson Innovation
Erin is responsible for developing and executing transactions with our diverse industry partners, including biotech companies, venture capital funds, non-profit organizations, governments, and academic institutions to access innovation across J&J’s areas of interest - our Pharmaceutical Therapeutic Areas, Consumer Need States, and Medical Device Businesses.
She leads all aspects of the deal process, developing value-creating deal structures, managing term sheet and contract negotiations, and driving the business case development and approval process. Erin also provides business and commercial analytics capabilities to the Boston IC team.
Prior to joining Johnson & Johnson, Erin was an Associate at Leerink Swann Consulting, where she advised on business development and corporate strategy for life sciences clients.
Erin holds a BA in Organismic and Evolutionary Biology from Harvard University.
Connect with Erin:   Follow on Twitter   Connect on LinkedIn

Johnson & Johnson Innovation, JLABS

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), New York City, and with Shanghai opening in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS.

Event contact

Related content